federal_register: E8-26020
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E8-26020 | Oral Dosage Form New Animal Drugs; Firocoxib Tablets | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Merial Ltd. The supplemental NADA provides for veterinary prescription use of firocoxib chewable tablets in dogs for the control of postoperative pain and inflammation associated with orthopedic surgery. | 2008-10-31 | 2008 | 10 | https://www.federalregister.gov/documents/2008/10/31/E8-26020/oral-dosage-form-new-animal-drugs-firocoxib-tablets | https://www.govinfo.gov/content/pkg/FR-2008-10-31/pdf/E8-26020.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Merial Ltd. The supplemental NADA provides for veterinary prescription use of firocoxib... |